Back to search

Article

Secretome proteomics-based targeting of inter-alpha-trypsin inhibitor heavy chain H2 (ITIH2) and clusterin (Clu) mitigates p53 amyloid–mediated tumorigenesis in oral carcinoma

2026-02-19

Abstract excerpt

<title>Abstract</title> <p>Oral cancer, a major form of head and neck cancer (HNC), remains clinically challenging due to its aggressiveness, and therapeutic resistance. Tumor microenvironment (TME) is one of the key factors of cancer progression which strongly influences how cancer cells survive, spread, and respond to treatment. However, the molecular factors underlying its dysregulation are not fully understoo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6f3542ec-7af6-54bc-bc9d-bab4a9762c92
DOI
10.21203/rs.3.rs-8727350/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Secretome proteomics-based targeting of inter-alpha-trypsin inhibitor heavy chain H2 (ITIH2) and clusterin (Clu) mitigates p53 amyloid–mediated tumorigenesis in oral carcinomaDOI 10.21203/rs.3.rs-8727350/v1
Select a neighboring publication to make it the new centre.